Reversal of Cushing's syndrome by vandetanib in medullary thyroid carcinoma
- PMID: 23924025
- DOI: 10.1056/NEJMc1301428
Reversal of Cushing's syndrome by vandetanib in medullary thyroid carcinoma
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical